166 related articles for article (PubMed ID: 21286077)
1. Hodgkin's Disease: Treatment and Prognosis.
Ing VW
Can Fam Physician; 1982 Mar; 28():487-91. PubMed ID: 21286077
[TBL] [Abstract][Full Text] [Related]
2. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
3. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
[TBL] [Abstract][Full Text] [Related]
4. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in Hodgkin's disease.
Brandt L; Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):185-97. PubMed ID: 11441931
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group.
Sieber M; Engert A; Diehl V
Ann Oncol; 2000; 11 Suppl 1():81-5. PubMed ID: 10707785
[TBL] [Abstract][Full Text] [Related]
7. [Hodgkin's lymphoma: problems in the treatment of the early stages].
Bacigalupo A; Barra S; Corvò R; Guenzi M; Scolaro T; Vitale V
Radiol Med; 1996 Nov; 92(5):620-3. PubMed ID: 9036456
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and therapy outcome in children with stage IV Hodgkin's lymphoma--the experience of two oncological centres].
Bień E; Stachowicz-Stencel T; Zawitkowska-Klaczyńska J; Adamkiewicz-Drozyńska E; Odój T; Połczyńska K; Mitura-Lesiuk M; Stefanowicz J; Sierota D; Szołkiewicz A; Birkholz D; Hennig M; Kowalczyk JR; Balcerska A
Med Wieku Rozwoj; 2006; 10(3 Pt 1):631-8. PubMed ID: 17317894
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease.
Diehl V; Josting A
Cancer J; 2000 Apr; 6 Suppl 2():S150-8. PubMed ID: 10803830
[TBL] [Abstract][Full Text] [Related]
13. Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.
Cosset JM; Fermé C; Noordijk EM; Dubray BM; Thirion P; Henry-Amar M
Semin Radiat Oncol; 1996 Jul; 6(3):185-195. PubMed ID: 10717177
[TBL] [Abstract][Full Text] [Related]
14. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
Donaldson SS; Hancock SL; Hoppe RT
Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
[TBL] [Abstract][Full Text] [Related]
15. The Challenge of Pediatric Hodgkin's Disease-Where is the Balance Between Cure and Long-Term Toxicity?: A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85.
Brämswig JH; Höornig-Franz I; Riepenhausen M; Schellong G
Leuk Lymphoma; 1990; 3(3):183-93. PubMed ID: 27457436
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
17. Re-visiting the role of radiation therapy in Hodgkin's disease.
Yahalom J
Isr J Med Sci; 1995; 31(2-3):137-43. PubMed ID: 7744583
[TBL] [Abstract][Full Text] [Related]
18. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
[TBL] [Abstract][Full Text] [Related]
19. The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone.
Provencio M; España P; Millán I; Sánchez A; Cantos B; Bonilla F
Leuk Lymphoma; 2003 Feb; 44(2):263-8. PubMed ID: 12688343
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
